Laboratory Total Current Liabilities from 2010 to 2024

LH Stock  USD 240.17  2.32  0.98%   
Laboratory's Total Current Liabilities is increasing with slightly volatile movements from year to year. Total Current Liabilities is estimated to finish at about 3.4 B this year. Total Current Liabilities is the total amount of liabilities that Laboratory of is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. View All Fundamentals
 
Total Current Liabilities  
First Reported
1989-03-31
Previous Quarter
4.1 B
Current Value
3.4 B
Quarterly Volatility
1.1 B
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 209.6 M, Total Revenue of 12.8 B or Gross Profit of 2 B, as well as many indicators such as Price To Sales Ratio of 1.57, Dividend Yield of 0.0122 or PTB Ratio of 3.28. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
  
Check out the analysis of Laboratory Correlation against competitors.

Latest Laboratory's Total Current Liabilities Growth Pattern

Below is the plot of the Total Current Liabilities of Laboratory of over the last few years. Total Current Liabilities is an item on Laboratory balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Laboratory of are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Laboratory's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.
Total Current Liabilities10 Years Trend
Slightly volatile
   Total Current Liabilities   
       Timeline  

Laboratory Total Current Liabilities Regression Statistics

Arithmetic Mean2,138,237,333
Geometric Mean1,559,070,549
Coefficient Of Variation51.24
Mean Deviation917,066,489
Median2,046,100,000
Standard Deviation1,095,676,130
Sample Variance1200506.2T
Range3.6B
R-Value0.69
Mean Square Error669454.1T
R-Squared0.48
Significance0
Slope170,127,929
Total Sum of Squares16807086.6T

Laboratory Total Current Liabilities History

20243.4 B
20233.2 B
20212.8 B
20203.1 B
20192.6 B
20181.9 B
2017B

About Laboratory Financial Statements

Investors use fundamental indicators, such as Laboratory's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Laboratory's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Current Liabilities3.2 B3.4 B

Currently Active Assets on Macroaxis

Check out the analysis of Laboratory Correlation against competitors.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Dividend Share
2.88
Earnings Share
5.26
Revenue Per Share
151.028
Quarterly Revenue Growth
0.074
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.